BTX-9341

N/A

Report date: 2026/05/20 20:02:01
NMEFirst In Class

Base Information

Drug NameBTX-9341
Drug Alias NameBTX-9341
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionCereblon modulatorsCyclin-dependent kinase 4 degradersCyclin-dependent kinase 6 degraders
TargetsCereblonCyclin-dependent kinase 4Cyclin-dependent kinase 6
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiotheryx Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiotheryx Inc
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A